CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 88 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $86,000 | -60.4% | 17,229 | +0.3% | 0.00% | -100.0% |
Q4 2020 | $217,000 | +29.2% | 17,184 | +0.5% | 0.00% | 0.0% |
Q3 2020 | $168,000 | -3.4% | 17,103 | -2.2% | 0.00% | 0.0% |
Q2 2020 | $174,000 | +24.3% | 17,492 | +10.4% | 0.00% | 0.0% |
Q1 2020 | $140,000 | +12.9% | 15,850 | +17.5% | 0.00% | – |
Q4 2019 | $124,000 | +55.0% | 13,490 | -0.8% | 0.00% | – |
Q3 2019 | $80,000 | -51.2% | 13,603 | -0.7% | 0.00% | -100.0% |
Q2 2019 | $164,000 | 0.0% | 13,697 | +0.9% | 0.00% | 0.0% |
Q1 2019 | $164,000 | -6.8% | 13,577 | -3.1% | 0.00% | 0.0% |
Q4 2018 | $176,000 | -16.2% | 14,018 | -0.8% | 0.00% | 0.0% |
Q3 2018 | $210,000 | -9.9% | 14,127 | +1.9% | 0.00% | 0.0% |
Q2 2018 | $233,000 | -11.1% | 13,870 | +21.1% | 0.00% | 0.0% |
Q1 2018 | $262,000 | -16.0% | 11,455 | -5.1% | 0.00% | 0.0% |
Q4 2017 | $312,000 | +76.3% | 12,071 | +0.5% | 0.00% | 0.0% |
Q3 2017 | $177,000 | +14.2% | 12,014 | +8.1% | 0.00% | 0.0% |
Q2 2017 | $155,000 | -10.4% | 11,116 | +9.5% | 0.00% | 0.0% |
Q1 2017 | $173,000 | +76.5% | 10,156 | +7.1% | 0.00% | – |
Q4 2016 | $98,000 | -99.9% | 9,479 | -0.3% | 0.00% | – |
Q3 2016 | $96,085,000 | -9.8% | 9,504 | +0.1% | 0.00% | – |
Q2 2016 | $106,573,000 | -13.4% | 9,490 | +5.4% | 0.00% | – |
Q1 2016 | $123,000,000 | -28.1% | 9,007 | 0.0% | 0.00% | -100.0% |
Q4 2015 | $171,000,000 | +101083.4% | 9,007 | -0.2% | 0.00% | 0.0% |
Q3 2015 | $169,000 | -99.9% | 9,023 | +0.1% | 0.00% | 0.0% |
Q2 2015 | $134,204,000 | – | 9,013 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |